Newland Pharmaceutical
301277
Shanghai Zhongzhou Special Alloy Materials
300963
Hefei Hengxin Life Science and Technology
301501
4
Tibet Duo Rui Pharmaceutical
301075
5
Dalian Demaishi Precision Technology
301007
CN Stock MarketDetailed Quotes
688191 Zhiyang Innovation Technology Co.,Ltd.
- 28.80
- +0.35+1.23%
Market Closed May 23 15:00 CST
4.48BMarket Cap104.73P/E (TTM)
29.30High28.38Low19.60KlotVolume28.46Open28.45Pre Close56.54MTurnover1.26%Turnover Ratio87.27P/E (Static)155.47MShares31.4452wk High5.02P/B4.48BFloat Cap13.8652wk Low34.14Limit Up155.47MShs Float31.44Historical High22.76Limit Down3.23%Amplitude8.81Historical Low0.30Dividend TTM28.84Avg Price8.58KlotAsk1.04%Div Yield TTM100Lot Size10.10KlotBid
Zhiyang Innovation Technology Co.,Ltd. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 28.92%279.57M | 24.55%944.66M | 20.79%618.65M | 38.98%414.28M | 112.01%216.85M | 7.79%758.45M | 30.43%512.16M | 13.99%298.09M | -46.43%102.29M | 26.74%703.65M |
| Refunds of taxes and levies | -73.24%1.48M | 4.40%26.2M | 2.36%15.49M | 81.35%11.68M | 140.04%5.55M | 56.78%25.1M | 51.50%15.13M | -3.14%6.44M | -59.03%2.31M | 17.89%16.01M |
| Cash received relating to other operating activities | 489.12%6.98M | 4.63%22.79M | 3.69%13.7M | -48.15%5.31M | -82.54%1.18M | -37.00%21.78M | 18.87%13.21M | 17.84%10.23M | 130.79%6.78M | -37.44%34.58M |
| Cash inflows from operating activities | 28.82%288.03M | 23.38%993.66M | 19.86%647.84M | 37.01%431.26M | 100.74%223.59M | 6.77%805.33M | 30.63%540.49M | 13.70%314.76M | -44.17%111.38M | 20.86%754.24M |
| Goods services cash paid | 46.90%188.2M | 41.03%543.94M | 42.46%408.13M | 42.40%247.49M | 215.98%128.11M | -12.82%385.68M | -10.85%286.49M | -23.72%173.8M | -69.93%40.54M | 4.87%442.37M |
| Staff behalf paid | 15.90%59M | 18.62%150.69M | 17.43%117M | 18.29%82.51M | 19.05%50.91M | 5.29%127.04M | 7.44%99.63M | 4.04%69.75M | 9.08%42.76M | 27.05%120.66M |
| All taxes paid | 40.09%27.68M | 44.25%78.51M | 62.30%58.69M | 139.52%45.92M | 169.71%19.75M | 7.38%54.42M | -8.55%36.16M | -38.20%19.17M | -54.77%7.32M | 12.13%50.69M |
| Cash paid relating to other operating activities | 28.63%41.92M | 15.00%147.36M | 0.38%91.9M | 4.44%60.21M | 15.35%32.59M | 13.34%128.14M | 17.96%91.55M | 20.39%57.65M | 15.69%28.25M | 0.25%113.06M |
| Cash outflows from operating activities | 36.93%316.8M | 32.39%920.5M | 31.51%675.73M | 36.13%436.12M | 94.61%231.37M | -4.33%695.29M | -3.28%513.83M | -14.30%320.37M | -44.61%118.88M | 7.70%726.78M |
| Net cash flows from operating activities | -269.77%-28.77M | -33.52%73.16M | -204.62%-27.89M | 13.32%-4.86M | -3.70%-7.78M | 300.77%110.04M | 122.69%26.66M | 94.22%-5.61M | 50.42%-7.5M | 154.10%27.46M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 36.36%628.01M | -8.97%1.43B | -3.60%973.89M | 23.11%794.46M | 48.43%460.57M | 57.14%1.57B | 32.29%1.01B | 12.29%645.3M | -8.93%310.3M | 111.27%999.33M |
| Cash received from returns on investments | -89.37%1.23M | 36.99%7.11M | 50.42%4.09M | 17.78%2.9M | 2,214.87%11.59M | 40.11%5.19M | -1.07%2.72M | 13.77%2.46M | -45.78%500.53K | 125.02%3.7M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | 378.22%382.58K | ---- | ---- | ---- | 433.33%80K | 433.33%80K | 433.33%80K | ---- | -73.58%15K |
| Cash inflows from investing activities | 33.27%629.25M | -8.80%1.44B | -3.47%977.98M | 23.08%797.36M | 51.92%472.15M | 57.08%1.58B | 32.18%1.01B | 12.31%647.84M | -9.04%310.8M | 111.30%1B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 881.25%92.22K | -27.32%30.26M | -6.49%19.64M | -82.33%3.7M | -99.95%9.4K | 159.15%41.64M | 199.01%21M | 217.73%20.95M | 576.77%20.13M | -86.14%16.07M |
| Cash paid to acquire investments | 2.46%660.82M | -16.15%1.45B | -9.46%1.17B | 28.46%944.65M | 35.39%644.95M | 68.10%1.73B | 54.47%1.29B | 20.77%735.35M | 31.81%476.35M | 117.63%1.03B |
| Cash paid relating to other investing activities | -93.61%1.32M | ---- | ---- | ---- | --20.66M | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -0.51%662.23M | -16.41%1.48B | -9.41%1.19B | 25.39%948.35M | 34.07%665.61M | 69.50%1.77B | 55.67%1.31B | 22.88%756.31M | 36.26%496.48M | 77.51%1.05B |
| Net cash flows from investing activities | 82.95%-32.99M | 77.50%-44.2M | 29.44%-212.07M | -39.22%-151M | -4.19%-193.46M | -363.25%-196.42M | -288.21%-300.55M | -180.88%-108.46M | -718.79%-185.68M | 62.89%-42.4M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --3.22M | 8,219.29%16.64M | 8,219.29%16.64M | --10.94M | ---- | -96.64%200K | -94.88%200K | ---- | ---- | -98.50%5.95M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | -90.48%200K | ---- | ---- | ---- | --2.1M |
| Cash from borrowing | --60M | 60.83%80.42M | --80M | --80M | ---- | 66.67%50M | ---- | ---- | ---- | --30M |
| Cash received relating to other financing activities | ---- | --6.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | --63.22M | 107.20%104.01M | 48,219.29%96.64M | --90.94M | ---- | 39.64%50.2M | -94.88%200K | ---- | ---- | -90.93%35.95M |
| Borrowing repayment | ---- | 339.52%131.86M | --30M | ---- | ---- | --30M | ---- | ---- | ---- | ---- |
| Dividend interest payment | ---- | 138.90%46.1M | 67.19%31.94M | 65.72%31.28M | -14.81%191.67K | -16.41%19.29M | -16.81%19.11M | --18.88M | --225K | -25.21%23.08M |
| Cash payments relating to other financing activities | ---- | --24.45M | --20.04M | --20.04M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from financing activities | ---- | 310.59%202.4M | 329.11%81.99M | 171.90%51.32M | -14.81%191.67K | 113.57%49.29M | -16.81%19.11M | --18.88M | --225K | -66.69%23.08M |
| Net cash flows from financing activities | 33,084.35%63.22M | -10,971.21%-98.39M | 177.50%14.65M | 309.90%39.62M | 14.81%-191.67K | -92.97%905.02K | 0.80%-18.91M | -2,066.27%-18.88M | ---225K | -96.07%12.87M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 100.73%1.46M | 18.77%-69.43M | 23.05%-225.31M | 12.57%-116.24M | -4.15%-201.43M | -4,017.90%-85.47M | -36.84%-292.79M | 1.25%-132.95M | -411.52%-193.41M | -101.28%-2.08M |
| Add:Begin period cash and cash equivalents | -26.37%193.82M | -24.51%263.25M | -24.51%263.25M | -24.51%263.25M | -24.51%263.25M | -0.59%348.72M | -0.59%348.72M | -0.59%348.72M | -0.59%348.72M | 85.87%350.8M |
| End period cash equivalent | 215.92%195.29M | -26.37%193.82M | -32.16%37.94M | -31.87%147.01M | -60.20%61.82M | -24.51%263.25M | -59.13%55.93M | -0.18%215.77M | -50.38%155.31M | -0.59%348.72M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.